Sign in
8-K

Current Report

Ultragenyx Pharmaceutical Inc. Filed Acc 0001564590-18-022207

Benefit plan blackout

  • Item 5.04 Temporary suspension of trading under employee benefit plans

From the SEC's structured data for this filing

Loading rare-8k_20180822.htm…